Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Products for Intimate Care and Cancer; Boost for Colorectal Cancer Stool Tests; Ultrasonic Biopsy?

2.

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

3.

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

4.

GLP-1 receptor agonists, cancer risk and questionable significance

5.

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot